source
- Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionCoultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune disea…Endpoints · 3mo ago↗ source
- Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingNovartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to s…Endpoints · 3mo ago↗ source
- Boehringer, Zealand’s obesity shot looks as good as Novo's Wegovy, but weaker than Lilly's ZepboundObesity patients taking the weight loss injection being developed by Boehringer Ingelheim lost nearly 17% of their weight after about a year and a half, the company said Tuesday. The results are mo…